Anixa Biosciences
ANIX | NASDAQ
$2.55
-$0.07 (-2.67%)
At close: Nov 16, 2026, 4:00 PM ET
$2.65
+$0.10 (+4.12%)
After-hours:
Nov 16, 2026, 7:53 PM ET
-2.67%
(1D)Rating
31.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #756/1021 (Top 74%)
Key Statistics
Market Data
Market Cap $88.65M
1D Range
2.54 2.70
52W Range
2.35 5.22
Valuation (TTM)
PE -8.50
PB 6.13
EV/EBITDA -7.10
Valuation (NTM)
Forward PE N/A
Forward PEG -8.06
Price Target $6.00
Cash Flow
FCF Yield -8.3%
SBC Adj. FCF Yield -10.6%
SBC Impact -27.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-50.0%
Dil EPS 3Y | 5Y 18.9% |
24.9%
FCF 3Y | 5Y 13.8% |
-5.5%
Returns
ROA -69.1%
ROE -70.4%
ROIC -82.1%
Financial Health
Net Cash
$13.86M
Current Ratio 8.54
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within...
Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Oct 7, 1983
Website www.anixa.com
Fiscal Year November - October
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$6.00
Upside
+135.29%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ANIX